KM
Kidron Miriam
Directeur Scientifique
OtherF
Insider track record
ExecutiveNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Kidron Miriam, Directeur Scientifique. Director active across 2 companies, notably Oramed Pharmaceuticals INC.. In total, 16 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €187k. History available since 14 March 2023. The latest transaction was filed on 30 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Kidron Miriam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
435,084 shares@ US$3.3187.0% of flowCommon StockSEC:0001213900-26-037446:0
7,657 shares0Ordinary Shares, no par value per shareSEC:0001178913-26-001812:0
119,558 shares0Common StockSEC:0001213900-26-031015:0
19,000 shares0Common StockSEC:0001213900-26-009478:0
86,166 shares0Common StockSEC:0001213900-26-006215:0
121,331 shares0Common StockSEC:0001213900-26-001279:0
74,000 shares0Common StockSEC:0001213900-25-012241:0
207,000 sharesCommon StockSEC:0001213900-25-001169:0
30,000 sharesCommon StockSEC:0001213900-24-095930:0
295,500 sharesCommon StockSEC:0001209191-24-001154:0
53,500 sharesCommon StockSEC:0001209191-23-033143:0
213,000 sharesCommon StockSEC:0001209191-23-024937:0
100,000 shares@ US$2.01100.0% of flowCommon StockSEC:0001209191-23-018952:0
34,000 sharesCommon StockSEC:0001209191-22-043769:0
42,000 sharesCommon StockSEC:0001213900-22-000816:0
66,666 sharesCommon StockSEC:0001213900-21-046411:0
About Kidron Miriam
Kidron Miriam is Chief Scientific Officer. She is linked to Oramed Pharmaceuticals INC. and Lifeward Ltd., with 16 filings in total. Across the 16 sampled filings, sales total 187412 EUR and the period runs from 2021-09-02 to 2026-03-31, with the modal transaction nature shown as Attribution.